BrainCool develops medical devices and therapies focused on targeted temperature management, including therapeutic hypothermia systems such as BrainCool, RhinoChill, and Cooral. These products are designed to protect the brain and vital organs by lowering body temperature, serving patients with conditions such as cardiac arrest, stroke, and cancer-related side effects.
Subscribe to see BrainCool’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BrainCool is a medical technology company headquartered in Sweden. Xcout tracks 10 named people at BrainCool, including Anna Lindström (CEO).
4 more named people on record for BrainCool, with roles, board committees and tenure — see the full roster →
A few of BrainCool's closest competitors — see the full list of competitors and alternatives →
Luciole Medical AG is a Swiss medical technology company founded in 2007 and headquartered in Zurich, Switzerland, specializing in cerebral monitoring solutions.
Dignitana produces and markets the DigniCap Scalp Cooling System, a patented medical device designed to minimize chemotherapy-induced hair loss. The system provides continuous scalp cooling to cancer patients undergoing treatment for solid tumors, helping to preserve their hair and improve their quality of life.
Brainlab develops hardware and software medical technology focused on surgery and radiation therapy. The company serves healthcare providers and physicians to help them treat cancer and other conditions of the brain and body.
Neofect provides clinically proven neurorehabilitation devices and software solutions designed to maximize arm and hand function through gamified therapy. The company serves stroke survivors and other patients through both home-based rehabilitation products and clinic tools, including smart gloves, boards, pegboards, and telehealth platforms.
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
NeuroBell is a medical device startup headquartered in Cork, Ireland, founded in 2022. The company develops specialized neurological monitoring technology and medical equipment designed for neonatal care and brain monitoring.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.